Apiam finds dual tailwinds in the market for custom animal health vaccines

Investor News

Stockhead Health & Biotech update

Special Report: The company’s strategic acquisition of ACE Laboratories is paying dividends as farmers seek alternatives to antibiotic health treatments.

Shares in animal health company Apiam (ASX:AHX) have almost doubled since March, amid a surge in pet ownership following the COVID-19 pandemic.